Reason for request
Reassessment of the IAB.
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités reste important.
|
Clinical Added Value
| minor |
la Commission maintient l'ASMR IV attribuée le 2 juin 2004 à RISPERDALCONSTA en tant que modalité d'administration susceptible d'améliorer la prise en charge de ces patients.
|
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
csx6sMU4KEcL4cRu
